Modelled DT Structure
Method: homology modeling
Template PDB: 7BP3_A
Identity: 45.61%
Minimized Score: -944.326 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0107 | ||||
| Gene Name | SLC16A3 | ||||
| Protein Name | Monocarboxylate transporter 4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 7BP3_A Identity: 45.61% Minimized Score: -944.326 kcal/mol Detail: Structure Info |
||||
| Synonyms | MCT 4; MCT4; SLC16A3; Solute carrier family 16 member 3 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Monocarboxylate Transporter (MCT) Family | |||||
| Tissue Specificity | Highly expressed in skeletal muscle. | ||||
| Function | This proton-linked monocarboxylate transporter catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. | ||||
| Endogenous Substrate(s) | Monocarboxylates; Lactate; pyruvate; Branched-chain oxo acids | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
|
(δ) Xenobiotics-regulated Structural Variability |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| L-lactate | EM Info | Identified using MCT4-attenuated mice | [1] | ||
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Investigative Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Milchsaure | Investigative | Drug Info | Oocytes-MCT4 | Km = 28 microM | [2] |
| References | |||||
| 1 | GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts. Int J Cancer. 2017 Nov 15;141(10):2131-2142. | ||||
| 2 | Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol. 2000 Dec 1;529 Pt 2:285-93. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.